Back

Data on detection of bladder cancer tumors

DETECTION OF BLADDER CANCER TUMORS: A META-ANALYSIS OF STUDIES 16
TUMOR TYPE BOTH METHODS, n (%) BL ONLY, n (%) WL ONLY, n (%) TOTAL ODDS RATIO (CI) IN FAVOR OF BL p VALUE
Total Ta 1298 (80.1) 239 (14.7) 84 (5.2) 1621 4.898 (1.937-12.390) <0.001
Ta Primary 495 (86.7) 64 (11.2) 12 (2.1) 571 5.146 (2.109-12.554) <0.001
Ta Recurrent 803 (76.5) 175 (16.7) 72 (6.9) 1050 4.637 (1.739-12.364) 0.002
High risk 460 (77.3) 94 (15.8) 41 (6.9) 595 3.635 (1.474-8.966) 0.005
Intermediate risk 674 (79.9) 138 (16.4) 32 (3.8) 844 7.056 (2.376-20.990) 0.005
Low risk 164 (90.1) 7 (3.8) 11 (6.0) 182 0.849 (0.279-2.583) 0.773
Total T1 313 (84.1) 40 (10.8) 19 (5.1) 372 2.253 (0.999-5.081) 0.050
Primary 201 (84.5) 30 (12.6) 7 (2.9) 238 4.478 (1.868-10.737) 0.001
Recurrent 112 (83.6) 10 (7.5) 12 (9.0) 134 0.962 (0.315-2.941) 0.946
Total CIS 285 (54.1) 215 (40.8) 27 (5.1) 527 12.372 (6.343-24.133) <0.001
Primary* 119 (54.6) 94 (43.1) 5 (2.3) 218 21.316 (8.163-55.661) <0.001
Recurrent* 166 (53.7) 121 (39.2) 22 (7.1) 309 7.947 (4.629-13.644) <0.001
*Primary and recurrent refer to the diagnosis of the patient at study entry
BL = blue-light | CI = confidence interval | CIS = carcinoma in situ | WL = white light
Adapted from Burger et al. 2013